Skip to main content

Table 1 Maternal cohort characteristics

From: Does in utero HIV exposure and the early nutritional environment influence infant development and immune outcomes? Findings from a pilot study in Pretoria, South Africa

Maternal characteristics

HIV uninfected (n = 22)

HIV infected (n = 32)

p value

Weight at delivery (kg)

60.1 (55.0, 80.3)

60.4 (56.0, 69.0)

0.85

Age (years)

28.1 ± 7.31

30.8 ± 5.91

0.13

Gravidity (n)

2.00 (1.50, 4.00)

3.00 (2.00, 3.00)

0.22

Parity (n)

2.00 (1.00, 3.00)

2.00 (1.00, 3.00)

0.95

Level of education (n)

 Primary

1

6

 

 Secondary

17

24

 

 Post-secondary

4

1

 

 Not indicated

–

1

 

Current ART (n)

   

 TDF, FTC, EFV

–

28

 

 AZT, 3TC, LPV/r

–

1

 

 None

 

3

 
  1. Data are means ± SD (ANOVA to test equality of means for normal data with equal variance) or median (IQR; Kruskal-Wallis/Wilcoxon test to test equality of medians for non-parametric data)
  2. TDF tenofovir, FTC emtricitabine, EFV efavirenz, AZT azidothymidine, 3TC lamivudine, LPV/r ritonavir-boosted lopinavir